October 28, 2019 – PALM BEACH COUNTY – The Business Development Board (BDB), Palm Beach County’s official economic development organization, facilitates the relocation, retention and expansion of companies to or in Palm Beach County by constantly strengthening local businesses one at a time and accelerating the economic future with high-wage and high-tech jobs. One such company that was recently assisted is ADMA Biologics, a publicly traded biopharmaceutical company located in Boca Raton.
ADMA plans to create several new jobs in Palm Beach County’s life science sector as the company scales up to produce three FDA approved drug products from the company’s Boca Raton biopharmaceutical manufacturing and laboratory facilities. The Business Development Board and the City of Boca Raton have worked together with the company to provide technical assistance necessary to facilitate the company’s growth in Boca Raton. They assisted with permits, locating vendors, and introducing a talent pipeline. The company acquired the Boca Raton Facilities in June of 2017 and has been in growth mode since receiving its recent FDA approvals. The company plans to hire approximately 100 jobs in a variety of areas in addition to retaining the existing workforce of approximately 250 at its Boca Raton campus.
ADMA Biologics provides life-saving medications to immune deficient patients with a genetic disorder called Primary Immune Deficiency Disease (“PI”), which affects more than 250,000 people in the U.S. PI is a class of inherited genetic disorders that causes an individual to have a deficient or absent immune system due to either a lack of necessary antibodies or a failure of these antibodies to function properly. ADMA Biologics is trying to change the future in immunotechnology with its three United States Food and Drug Administration (“FDA”) approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases.
Adam Grossman, Founder and CEO of ADMA said, “We are really happy to be a part of the growing life sciences community here in Florida. We are grateful to the Palm Beach County Business Development Board for their dedication to the life-sciences industry and believe that being able to partner with the County and City to bring jobs to the community is a win-win for business and the government.”
“With five U.S. patents, ADMA is trailblazing in its industry with groundbreaking science and we’re happy they’re doing it right here in Boca Raton,” said Kelly Smallridge, President and CEO of the Business Development Board.
“Boca Raton’s life sciences industry is home to many companies leading the way with cutting-edge innovations. Boca is excited to support the growth of ADMA Biologics,” said Mayor Scott Singer, Mayor of Boca Raton.
About ADMA Biologics: ADMA Biologics is a biopharmaceutical company relentlessly committed to creating superior products for immunodeficient patients at risk for infection. It is our devotion to this underserved population that fuels us, and our hands-on approach to production and development that sets us apart. ADMA Biologics is a commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatments of immunodeficient patients at risk for infection. ADMA currently manufactures and markets three United States Food and Drug Administration (“FDA”) approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: ASCENIV™ (immune globulin intravenous, human – slra 10% liquid) for the treatment of primary humoral immunodeficiency (PI); BIVIGAM® (immune globulin intravenous, human) for the treatment of PI; and NABI-HB® (hepatitis B immune globulin, human) to provide enhanced immunity against hepatitis B. ADMA’s mission is to manufacture, market and develop specialty plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases and management of immune compromised patient populations who suffer from an underlying immune deficiency disease, or who may be immune compromised for other medical reasons. ADMA has received U.S. Patents: 9,107,906, 9,714,283, 9,815,886, 9,969,793 and 10,259,865 related to certain aspects of its products and product candidates. For more information, please visit www.admabiologics.com.
About Business Development Board: The Business Development Board of Palm Beach County is the official public/private economic development organization for Palm Beach County and Enterprise Florida. Founded in 1982 as a not-for-profit corporation, our primary purpose is to attract and retain new industry, business investment, high quality jobs and workforce development through corporate relocations, expansions and international trade. During the past five years, the BDB has assisted companies that have created more than 12,822 direct jobs with average salaries greater than $69,062, resulting in more than $777 million in capital investment to Palm Beach County and an economic impact that exceeds $6.87 billion. Additional information can be found at the BDB’s web site, BDB.org.